Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ariëns

Showing results (21-30 of 128) with videos related to

Pageof 13
Sort By:
Blood|March 29, 2003
Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structureAmy V Cooper, Kristina F Standeven, Robert A S Ariëns
Journal of Thrombosis and Haemostasis : JTH|January 4, 2026
Novel and Experimental Anticoagulant Strategies Beyond Current DOACsHolly C Dobbing, Katherine L Webb, Robert A S Ariëns
Journal of the American Heart Association|October 17, 2022
Platelet-Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic ApproachesJulia S Gauer, Ramzi A Ajjan, Robert A S Ariëns
Diabetologia|May 3, 2005
The influence of type 2 diabetes on fibrin structure and functionE J Dunn, R A S Ariëns, P J Grant
Advances in Protein Chemistry and Structural Biology|May 17, 2011
Role of fibrin structure in thrombosis and vascular diseaseAmy L Cilia La Corte, Helen Philippou, Robert A S Ariëns
Acta Biomaterialia|October 11, 2024
Fibrinogen αC-region acts as a functional safety latch: Implications for a fibrin biomechanical behaviour modelTímea Feller, Helen R McPherson, Simon D Connell, et al.
Seminars in Thrombosis and Hemostasis|April 13, 2016
The (Patho)physiology of Fibrinogen γ'Fraser L Macrae, Marco M Domingues, Alessandro Casini, et al.
Diabetologia|March 16, 2006
Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitusE J Dunn, H Philippou, R A S Ariëns, et al.
Transfusion|September 12, 2015
Effects of riboflavin and amotosalen photoactivation systems for pathogen inactivation of fresh-frozen plasma on fibrin clot structureThomas Hubbard, Lucy Backholer, Michael Wiltshire, et al.
Thrombosis Research|September 13, 2014
CVD risk factors are related to plasma fibrin clot properties independent of total and or γ' fibrinogen concentrationRetha C M Kotzé, Robert A S Ariëns, Zelda de Lange, et al.
Pageof 13

Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
Blood|March 29, 2003
Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structureAmy V Cooper, Kristina F Standeven, Robert A S Ariëns
Journal of Thrombosis and Haemostasis : JTH|January 4, 2026
Novel and Experimental Anticoagulant Strategies Beyond Current DOACsHolly C Dobbing, Katherine L Webb, Robert A S Ariëns
Journal of the American Heart Association|October 17, 2022
Platelet-Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic ApproachesJulia S Gauer, Ramzi A Ajjan, Robert A S Ariëns
Diabetologia|May 3, 2005
The influence of type 2 diabetes on fibrin structure and functionE J Dunn, R A S Ariëns, P J Grant
Advances in Protein Chemistry and Structural Biology|May 17, 2011
Role of fibrin structure in thrombosis and vascular diseaseAmy L Cilia La Corte, Helen Philippou, Robert A S Ariëns
Acta Biomaterialia|October 11, 2024
Fibrinogen αC-region acts as a functional safety latch: Implications for a fibrin biomechanical behaviour modelTímea Feller, Helen R McPherson, Simon D Connell, et al.
Seminars in Thrombosis and Hemostasis|April 13, 2016
The (Patho)physiology of Fibrinogen γ'Fraser L Macrae, Marco M Domingues, Alessandro Casini, et al.
Diabetologia|March 16, 2006
Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitusE J Dunn, H Philippou, R A S Ariëns, et al.
Transfusion|September 12, 2015
Effects of riboflavin and amotosalen photoactivation systems for pathogen inactivation of fresh-frozen plasma on fibrin clot structureThomas Hubbard, Lucy Backholer, Michael Wiltshire, et al.
Thrombosis Research|September 13, 2014
CVD risk factors are related to plasma fibrin clot properties independent of total and or γ' fibrinogen concentrationRetha C M Kotzé, Robert A S Ariëns, Zelda de Lange, et al.
Pageof 13